Catalyst intelligence · independently researched · Public releaseNew Jersey · Eastern Time
NLTHE NKENGBEZA LEDGERby Nyochembeng Nkengbeza
Menu
Coverage
Science
BiotechMedicine
Technology
HardwareSoftware
Finance
Real EstateBanking
Research
Research record
Active ResearchHistorical CalibrationCommentaryFiling Changes
Ledger
Evidence tools
Catalyst RadarOccurrence LedgerOutcome LedgerCompany Baselines
Access
Membership & services
PlansServices
ScienceBiotech

BIOTECH CATALYST CALENDAR

Know what may change the story, and when.

A sourced schedule of biotech catalysts. Each entry identifies the announced fact, the expected window and the evidence needed to judge what happened next.

Category catalyst tracking
01

Sourced

Every published date links to the primary or official source used.

02

Windowed

Uncertain timing is shown as a range instead of false date precision.

03

Tracked

Resolved events connect to the Outcome Ledger as evidence accumulates.

PUBLISHED CATALYST EVENTS

Biotech catalyst schedule

1 published event

Earnings · completed

Q2 genomic test-mix gains

GeneDx NASDAQ: WGS

Q2 revenue reached $114.4 million, including $100.3 million of exome and genome revenue on 30,785 tests. Still unestablished: durable mix, reimbursement, collections, turnaround, diagnostic utility and operating quality. Calendar corrected: completed August 3 Q2 results, not a confirmed Q3 date.

Primary source
How to read this calendar

A calendar entry identifies a dated event to monitor. It is not a prediction that the event will occur, an estimate of market reaction, or a recommendation to buy or sell a security. Expected windows can change when companies or regulators update their schedules.